Venom allergy

Summary

Venom allergy (MONDO:0600005) is a disease and 5 clinical trials. A subtype of allergic disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 5

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	venom allergy
Mondo ID	MONDO:0600005
UMLS	C4510560
MedGen	1387536
Is cancer (heuristic)	no

Also known as: IgE-mediated venom hypersensitivity · venom hypersensitivity

Disease family

This is a subtype of allergic disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › immune system disorder › hypersensitivity reaction disease › allergic disease › venom allergy

Related subtypes (11): allergic respiratory disease, drug allergy, gastrointestinal allergy, latex allergy, atopic eczema, atopic IgE-mediated allergic disorder, eye allergy, vulvovaginitis, allergic seminal, allergic otitis media, alpha-gal syndrome, food allergy

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 5.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	3
PHASE4	2

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06935890	PHASE4	RECRUITING	Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation
NCT00684476	PHASE4	COMPLETED	Maintenance Bee-Venom Immunotherapy Administered at 6-Month Intervals Does Not Protect Against re-Stings
NCT06876506	Not specified	NOT_YET_RECRUITING	Identification of B Regulatory Cells by Flow Cytometry
NCT07328178	Not specified	RECRUITING	Analysis of the Role of IgE Proteoforms in Health and Disease
NCT07596303	Not specified	NOT_YET_RECRUITING	BÜHLMANN BAT (Basophil Activation Test) in Allergy Diagnosis (Exploratory Pilot Study)